Skip to content

Checked

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

NCT07391657 on ClinicalTrials.gov

Study listings come from ClinicalTrials.gov, where sponsors register and update their own studies. A listing does not mean a study is safe or effective, and DatenUS does not recommend any study. Talk with your doctor before joining a clinical trial, and use ClinicalTrials.gov for contact details and full eligibility rules.

Status
Recruiting
Phase
Phase 3
Interventional
Planned enrollment
508
Participants, all sites
U.S. sites
51
In 25 states

Study details

Conditions
Relapsed Refractory Multiple Myeloma
Sponsor
AstraZeneca (Industry)
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Start
02/23/2026
Primary completion (expected)
06/14/2028
Last updated by sponsor
09/29/2026

Full eligibility rules, contacts and site names: NCT07391657 on ClinicalTrials.gov

Where the study has sites

Cities with at least one listed U.S. site. Some sites may not be enrolling yet.

  • Arizona: Gilbert, Phoenix, Tucson
  • California: La Jolla, Sacramento, Santa Monica
  • Colorado: Denver
  • Connecticut: New Haven
  • District of Columbia: Washington D.C.
  • Florida: Coral Gables, Tampa
  • Georgia: Atlanta
  • Illinois: Chicago, Park Ridge
  • Iowa: Iowa City
  • Kansas: Kansas City
  • Kentucky: Louisville
  • Massachusetts: Boston (3)
  • Michigan: Detroit (2)
  • Minnesota: Rochester
  • New York: New York (4), Albany, Rochester, The Bronx
  • North Carolina: Charlotte (2), Winston-Salem (2), Chapel Hill
  • Ohio: Cincinnati, Cleveland
  • Oregon: Portland
  • South Carolina: Charleston
  • Tennessee: Nashville
  • Texas: Austin, Dallas, Houston
  • Utah: Salt Lake City
  • Virginia: Charlottesville, Gainesville, Richmond
  • Washington: Puyallup, Seattle
  • Wisconsin: Madison, Milwaukee

More studies on the same topic

Frequently asked questions

What does recruiting mean?
Recruiting means the study is currently enrolling participants. Not yet recruiting means it has been registered but has not started enrolling. Enrolling by invitation means participants are selected by the study team rather than through open enrollment.
How do I join a clinical trial?
Read the full eligibility criteria and contact information on ClinicalTrials.gov, then talk with your doctor about whether a study may be right for you. The study team decides who can enroll.

Source: ClinicalTrials.gov, National Library of Medicine · Last updated 09/29/2026